Robert
Casson
Australia
Sessions
Friday 1.45 pm-3.15 pmRoom 203 & 204
ANZGS Symposium - The Gillies Lecture, and A Showcase of Glaucoma Research from Australian and NewZealand Universities
Chair(s): Anne Brooks (Australia); Keith Martin (United Kingdom); Ivan Goldberg (Australia);
- 1.45-2.05
The Gillies Lecture: Of Glaucoma, Prevention of Blindness & the Reverend: A personal Khichdi
Ravi Thomas (Australia) - 2.05-2.15
Connexin 43 in Retinal Ganglion Cell Injury
Helen Danesh-Meyer (New Zealand) - 2.15-2.25
Promoting retinal ganglion cell recovery
Jonathan Crowston (Australia) - 2.25-2.35
Novel approaches to neuroprotection TrkB/Shp2, neuroserpin and RXRs
Stuart Graham (Australia) - 2.35-2.45
Bioenergetic Neuroprotetction in Glaucoma
Robert Casson (Australia) - 2.45-2.55
Translaminar pressure gradient and glaucoma
Bill Morgan (Australia) - 2.55-3.05
Machine learning and optic DISC assessment for glaucoma
John Grigg (Australia) - 3.05-3.15
Clinical and molecular risk factors for glaucoma progression and blindness
James Craig (Australia)
Friday 3.45 pm-4.45 pmRoom 217
Integrating genetics into clinical practice
Chair(s): Robert Casson (Australia); Eranga Vithana (Singapore);
- 3.45-3.57
The future of genetics
Stuart MacGregor (Australia) - 3.57-4.09
How do you find & motivate family members to seek care?
Annie Gibbins (Australia) - 4.09-4.21
What genetics cause glaucoma & where can you get them tested?
Susie Williams (South Africa) - 4.21-4.33
Considering age, type of glaucoma, and other factors to screen family members intelligently
Srinivasan Kavitha (India) - 4.33-4.45
Practical tips about when and how to implement genetic screening in clinical practice
John Fingert (United States)
